Bradley Nicholas A, Roxburgh Campbell S D, McMillan Donald C, Guthrie Graeme J K
New Lister Building, University of Glasgow, Glasgow, United Kingdom.
New Lister Building, University of Glasgow, Glasgow, United Kingdom.
Surgeon. 2025 Feb;23(1):e1-e8. doi: 10.1016/j.surge.2024.08.014. Epub 2024 Aug 26.
Activation of the systemic inflammatory response (SIR) is associated with inferior outcomes across a spectrum of disease. Routinely available measures of the SIR (neutrophil:lymphocyte ratio (NLR), platelet:lymphocyte ratio (PLR), systemic immune-inflammatory index (SII), systemic inflammatory grade (SIG)) have been shown to provide prognostic value in patients undergoing surgical intervention. The present study aimed to review the literature describing the prognostic association of NLR, PLR, SII and SIG in patients undergoing intervention for abdominal aortic aneurysm (AAA).
This PRISMA guidelines were followed. The MEDLINE database was interrogated for relevant studies investigating the effect of peri-operative systemic inflammation-based prognostic systems on all-cause mortality in patients undergoing OSR and EVAR for AAA. Inter-study heterogeneity precluded meaningful meta-analysis; qualitative analysis was instead performed.
There were 9 studies included in the final review reporting outcomes on a total of 4571 patients; 1256 (27 %) patients underwent OSR, and 3315 (73 %) patients underwent EVAR. 4356 (95 %) patients underwent a procedure for unruptured AAA, 215 (5 %) patients underwent an emergency procedure for ruptured AAA0.5 studies reported early (inpatient or 30-day) mortality; 2 of these found that elevated NLR predicted inferior survival, however PLR did not provide prognostic value. 6 studies reported long-term mortality; elevated NLR (5 studies), PLR (1 study), and SIG (1 study) predicted inferior survival.
It appears that activation of the SIR is associated with inferior prognosis in patients undergoing intervention for AAA, however the evidence is limited by heterogenous methodology and lack of consensus regarding optimal cutoff.
CRD42022363765.
全身炎症反应(SIR)的激活与一系列疾病的不良预后相关。常规可用的SIR指标(中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、全身免疫炎症指数(SII)、全身炎症分级(SIG))已被证明在接受手术干预的患者中具有预后价值。本研究旨在回顾描述NLR、PLR、SII和SIG在接受腹主动脉瘤(AAA)干预患者中的预后关联的文献。
遵循PRISMA指南。检索MEDLINE数据库,查找有关围手术期基于全身炎症的预后系统对接受开放手术修复(OSR)和腔内修复术(EVAR)治疗AAA患者全因死亡率影响的相关研究。研究间的异质性妨碍了有意义的荟萃分析;取而代之的是进行定性分析。
最终综述纳入了9项研究,共报告了4571例患者的结局;1256例(27%)患者接受了OSR,3315例(73%)患者接受了EVAR。4356例(95%)患者接受了未破裂AAA手术,215例(5%)患者接受了破裂AAA的急诊手术。5项研究报告了早期(住院或30天)死亡率;其中2项发现NLR升高预示生存较差,然而PLR没有提供预后价值。6项研究报告了长期死亡率;NLR升高(5项研究)、PLR升高(1项研究)和SIG升高(1项研究)预示生存较差。
似乎SIR的激活与接受AAA干预患者的预后较差相关,然而证据受到方法异质性和缺乏关于最佳临界值共识的限制。
PROSPERO数据库注册号:CRD42022363765。